All Posts:lung cancer
-
Rare but Important Gene Target Found in Many Tumor Types, Suggesting New Therapy Possible
A consortium of researchers led by Georgetown Lombardi Comprehensive Cancer Center investigators have completed the largest analysis of a new gene fusion they believe is responsible for development of a wide spectrum of cancer types.
Category: News Release
-
Georgetown-Led Study Leads to First FDA-Approved Drug in Decades to Improve Survival in Small Cell Lung Cancer
The U.S. Food and Drug Administration’s approval of a drug used in combination with chemotherapy for the initial treatment of extensive-stage small cell lung cancer marks the end of numerous failed attempts to improve survival for those with the deadly disease.
Category: Lombardi Stories